Abstract
Prostate cancer is now the most commonly diagnosed male cancer in Europe. Histopathology, the current gold standard for diagnosing prostate pathology is subjective and limited by intra and inter-observer variation. Fourier transform infrared spectroscopy (FTIR) enables objective tissue analysis on the basis of biochemical and structural tissue components. This study examined FTIR’s ability to discriminate between benign, premalignant and malignant prostate pathologies. Biochemical fitting using non negative least squares was performed on the spectral datasets of individual prostate pathologies. This novel technique was applied to estimate the relative concentrations of the dominant components in prostate tissue from different prostate pathologies. Preliminary results of the biochemical fitting were promising and gave an early insight into possible biomarkers which could be used in the future to classify stages of the carcinogenesis process. The Principal Component Analysis fed Linear Discriminant Analysis enabled good separation of the pathologies with sensitivities and specificities comparable with the gold standard histopathology. Further work will develop the biochemical fitting technique and increase sample size.
© 2007 SPIE
PDF ArticleMore Like This
Rebecca N. Baker, Keith D. Rogers, Neil Shepherd, and Nicholas Stone
6628_18 European Conference on Biomedical Optics (ECBO) 2007
J. J. Wood, C. Kendall, G. R. Lloyd, N. A. Shepherd, T. A. Cook, and N. Stone
80870P European Conference on Biomedical Optics (ECBO) 2011
Suse J. van Breugel, Liam Quinn, Hannah Holtkamp, Ariane Araquel-Lacamiento, Satya Amirapu, Komal K. Srinivasa, Irene Low, Mary L. Christie, Michel K. Nieuwoudt, Morgan R. Pokorny, Ramya Nagarajan, M. Cather Simpson, Kamran Zargar-Shoshtari, and Claude Aguergaray
TM2B.4 Clinical and Translational Biophotonics (Translational) 2022